Choksi Laboratories withdraws registration of Indore facility from USFDA
1st Oct 2019

Choksi Laboratories (CLL) has voluntarily withdrawn registration of existing Indore facility from United States Food & Drug Administration (USFDA). To continue serving to US, Canada and North American markets, Company is planning to apply for requisite registrations under its new state-of-the art facility in Indore spreading over 1 lakh sq. ft.

Choksi Laboratories is widely known as a leading analysis and research group, providing complete solutions for improving quality in processes, products and services.